Apogee Therapeutics (APGE) Return on Equity [ROE] (2023 - 2026)
Apogee Therapeutics (APGE) recorded Return on Equity [ROE] of -24.03% in Q2 2026, up 12.74 percentage points from -36.77% a year earlier and up 1.40 percentage points from the prior quarter.
Powered by 
Analysis
Apogee Therapeutics (APGE) Return on Equity [ROE] (2023 - 2026) Analysis & Trends
For FY2025, Apogee Therapeutics reported Return on Equity [ROE] of -31.57%, up 1.64 percentage points from FY2024.
- Across earlier years, Return on Equity [ROE] came in at -33.22% in FY2024 (+15.54 pp) and -48.75% in FY2023.
- The Q2 2026 figure is the highest quarterly Return on Equity [ROE] since Q3 2024.
- On a year-over-year basis, Return on Equity [ROE] rose in three of the last eight quarters, with an average year-over-year change of -4.19 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 19.03 percentage points in Q3 2024, against a drop of 22.63 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -25.43% (Q1 2026), -34.34% (Q4 2025) and -42.08% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Apogee Therapeutics | 10.18 Bn | 7.68 Bn | - | -24.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.03% |
| Mar 31, 2026 | -25.43% |
| Dec 31, 2025 | -34.34% |
| Sep 30, 2025 | -42.08% |
| Jun 30, 2025 | -36.77% |
| Mar 31, 2025 | -29.55% |
| Dec 31, 2024 | -25.10% |
| Sep 30, 2024 | -19.45% |
| Jun 30, 2024 | -15.04% |
| Mar 31, 2024 | -17.53% |
| Dec 31, 2023 | -21.28% |
| Sep 30, 2023 | -38.48% |
API Access
Apogee Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=APGE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "APGE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=APGE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();